HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Better understanding of disease biology triggers ‘revolution’ in male breast cancer
• American College of Radiology elects officers, presents awards
• ASCO establishes leadership award
• Hematology/Oncology Pharmacy Association inducts first fellows class
• Increased awareness, expanded trial access ‘could save lives’ of men with breast cancer
• Ohio State names chair of surgery department
• Sarah Cannon Research Institute announces two promotions
• Cancer and the world economy (Please read this, Vice President Biden!) Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
• FDA approves Afstyla to treat patients with hemophilia A
• FDA approves Axumin to detect recurrent prostate cancer
• FDA approves Tecentriq, first anti–PD-L1 immunotherapy to treat bladder cancer
• FDA grants accelerated approval to Opdivo for classical Hodgkin lymphoma
• A 45-year-old woman with pulmonary venous metastasis from uterine leiomyosarcoma Munir Ghesani, MD, FACNM
• The denominator problem in clinical oncology William Wood, MD
• Afatinib shows promise for genetically mutated urothelial cancer
• Androgen suppression benefits men with rising PSA after prostatectomy
• Antibiotic use and cancer risk: Repeat exposure poses harm
• Benefit of increased resection extent varies by molecular subgroup in medulloblastoma
• Brain tumors affect adolescents and young adults differently, more frequently
• Cancer diagnosis increases risk for mental disorders, psychiatric medication use
• Colorectal cancer incidence rising in patients younger than screening age
• Cytogenetics, treatment variances may affect outcomes in pediatric t(8;21)-positive AML
• Despite advancements, men with severe hemophilia still experience frequent bleeding, disability
• Economic crisis, unemployment rates drive excess cancer deaths
• Emicizumab reduces bleeding in patients with severe hemophilia A
• Few cancer drugs demonstrate OS benefit at time of FDA approval
• Geriatric events increase morbidity, costs among older patients who undergo cancer surgery
• Grafts from younger, HLA-matched donors may improve HSCT outcomes
• Healthy diet, regular exercise reduce risk for deadly prostate cancers
• Height, weight in adolescence may contribute to non-Hodgkin’s lymphoma risk
• Hematologic oncologists likely to report having end-of-life discussions ‘too late’
• Invasive sampling remains common for pulmonary nodule management
• Link found between Parkinson's disease, melanoma
• Long-term imatinib treatment may improve OS, RFS in high-risk GISTs
• Microbiota profiles in patients with colorectal cancer differ from healthy individuals
• Older cancer survivors more likely to experience depression, difficulty with daily activities
• Patients with melanoma, autoimmune disorders require close monitoring with ipilimumab treatment
• PIK3CA mutations may predict response to combination treatment for HER-2–positive breast cancer
• Researchers estimate CAM use among elderly patients with cancer
• Researchers identify factors associated with survival in patients with submandibular gland tumors
• Select patients with CML may safely discontinue dasatinib
• Tissue biomarkers linked to shorter vascular leiomyosarcoma-specific survival
• Bedside sitting improves patient–nurse communication
• Biden: Moonshot requires ‘open collaboration, open minds’
• Chemoradiation improves OS, PFS in older patients with glioblastoma
• Chemotherapy nonadherence higher among black women with breast cancer
• CHG wipes may lower rates of central line-associated bloodstream infections
• Chimeric antigen receptor T cells exhibit efficacy in advanced lymphoma
• Early palliative care may improve quality of life for family caregivers
• Granisetron patch prevents CINV for patients with hematologic malignancies
• Higher BMI linked to improved survival for patients with metastatic colorectal cancer
• Hydroxyurea therapy improves lung function in children with sickle cell disease
• Majority of providers support medical marijuana use in children with cancer
• Metastatic breast cancer research initiative benefits from direct-to-patient recruitment
• Precision medicine approach improves outcomes in phase 1 trials
• Radiotherapy improves survival for patients with stage IIa testicular seminoma
• Upfront autologous HSCT superior to novel therapies for multiple myeloma